Page 772
Jan 18, 2018
Why Gene Silencing Could Launch a New Class of Blockbuster Drugs
Posted by Shailesh Prasad in category: biotech/medical
Over 85 percent of proteins in the body can’t be targeted with conventional chemical drugs. By working on the RNA responsible for problematic proteins, gene silencing opens up an enormous portion of the genome to intervention. If realized, a new class of drugs based on gene silencing could overhaul modern medicine.
Read more
Jan 18, 2018
How the Science of Decision-Making Will Help Us Make Better Strategic Choices
Posted by Shailesh Prasad in categories: energy, information science, science
Neuroscientist Brie Linkenhoker believes that leaders must be better prepared for future strategic challenges by continually broadening their worldviews.
As the director of Worldview Stanford, Brie and her team produce multimedia content and immersive learning experiences to make academic research and insights accessible and useable by curious leaders. These future-focused topics are designed to help curious leaders understand the forces shaping the future.
Continue reading “How the Science of Decision-Making Will Help Us Make Better Strategic Choices” »
Jan 18, 2018
This is the darkest material on Earth
Posted by Shailesh Prasad in categories: materials, space travel
Jan 18, 2018
This bed is making the lives of carers and patients easier
Posted by Shailesh Prasad in category: biotech/medical
Jan 18, 2018
CES 2018 gets serious about health, wellness and medical tech
Posted by Shailesh Prasad in categories: biotech/medical, health
Jan 18, 2018
Food store AI sees what you put in basket
Posted by Shailesh Prasad in categories: food, robotics/AI
Jan 18, 2018
Researchers Have Developed A New Way To Block Pain
Posted by Shailesh Prasad in category: neuroscience
For anyone who has accidentally injured themselves, Dr. Zachary Campbell not only sympathizes, he’s developing new ways to blunt pain.
“If you have ever hit yourself with a hammer, afterward, even a light touch can be painful for days or even weeks,” said Campbell, who researches pain on the molecular level at The University of Texas at Dallas. “While many of us may not be coordinated enough to avoid an accident, my goal is to disrupt the inception and persistence of pain memories.”
Campbell directs the Laboratory of RNA Control and recently published a study in the journal Nature Communications in close collaboration with Dr. Ted Price, an associate professor from the Pain Neurobiology Research Group, and Dr. Michael Burton, a new assistant professor from the School of Behavioral and Brain Sciences who conducted postdoctoral work at UT Dallas.
Continue reading “Researchers Have Developed A New Way To Block Pain” »
